We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
-11.25%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$346M
AUM Growth
-$62.4M
Cap. Flow
-$72M
Cap. Flow %
-20.82%
Top 10 Hldgs %
43.48%
Holding
66
New
4
Increased
9
Reduced
42
Closed
4

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.5M
2
SEIC icon
SEI Investments
SEIC
+$1.77M
3
SPGI icon
S&P Global
SPGI
+$1.47M
4
KEYS icon
Keysight
KEYS
+$1.43M
5
CDW icon
CDW
CDW
+$1.43M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$11.2M
2
MDLZ icon
Mondelez International
MDLZ
+$4.91M
3
MDT icon
Medtronic
MDT
+$4.71M
4
CTVA icon
Corteva
CTVA
+$4.61M
5
MSI icon
Motorola Solutions
MSI
+$4.11M

Sector Composition

Rank Sector Weight
1 Technology 24.42%
2 Healthcare 21.69%
3 Industrials 17.33%
4 Financials 15.26%
5 Consumer Staples 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
26
Linde
LIN
$236B
$5.02M 1.45%
17,445
-752
-4% -$235K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.46M 1.29%
16,323
ULTA icon
28
Ulta Beauty
ULTA
$21.8B
$4.38M 1.27%
7,955
-4,211
-35% -$1.67M
PFE icon
29
Pfizer
PFE
$143B
$4.28M 1.24%
63,698
-21,941
-26% -$1.12M
ROST icon
30
Ross Stores
ROST
$80.8B
$4.18M 1.21%
45,277
-21,844
-33% -$1.95M
ALSN icon
31
Allison Transmission
ALSN
$9.51B
$4.12M 1.19%
107,176
-3,112
-3% -$119K
OTIS icon
32
Otis Worldwide
OTIS
$27.9B
$4.09M 1.18%
57,931
-1,540
-3% -$113K
CME icon
33
CME Group
CME
$95.4B
$4.09M 1.18%
13,543
-6,740
-33% -$1.43M
RTX icon
34
RTX Corp
RTX
$290B
$4.08M 1.18%
42,462
+787
+2% +$75.7K
META icon
35
Meta Platforms (Facebook)
META
$1.49T
$3.98M 1.15%
24,689
-598
-2% -$115K
TFC icon
36
Truist Financial
TFC
$63.9B
$3.88M 1.12%
81,869
-2,696
-3% -$133K
SONY icon
37
Sony
SONY
$137B
$3.83M 1.11%
90,320
-123,575
-58% -$2.19M
PM icon
38
Philip Morris
PM
$309B
$3.65M 1.06%
24,447
-110,054
-82% -$11.2M
CSCO icon
39
Cisco
CSCO
$443B
$3.57M 1.03%
83,787
-62,288
-43% -$2.98M
CPRT icon
40
Copart
CPRT
$28.5B
$3.46M 1%
103,284
-23,200
-18% -$660K
BDX icon
41
Becton Dickinson
BDX
$46.4B
$3.1M 0.9%
12,596
-3,814
-23% -$968K
NVS icon
42
Novartis
NVS
$302B
$2.69M 0.78%
11,172
-20,508
-65% -$1.8M
WMT icon
43
Walmart Inc
WMT
$909B
$2.43M 0.7%
59,850
HUM icon
44
Humana
HUM
$43.9B
$2.3M 0.66%
4,911
+170
+4% +$75.6K
SNY icon
45
Sanofi
SNY
$107B
$2.08M 0.6%
5,464
-39,430
-88% -$2.09M
RELX icon
46
RELX
RELX
$66.7B
$1.96M 0.57%
7,608
-59,862
-89% -$1.72M
ABBV icon
47
AbbVie
ABBV
$465B
$1.88M 0.54%
12,242
WTW icon
48
Willis Towers Watson
WTW
$29.8B
$1.84M 0.53%
9,327
-277
-3% -$59.4K
SEIC icon
49
SEI Investments
SEIC
$12.3B
$1.7M 0.49%
+31,373
New +$1.77M
CTVA icon
50
Corteva
CTVA
$60.5B
$1.58M 0.46%
29,260
-79,338
-73% -$4.61M

Similar funds

Foyston, Gordon, & Payne's Q2 2022 Portfolio in Review

As of Q2 2022, Foyston, Gordon, & Payne held 66 positions worth $346M, down 15% from $408M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $72M in Q2 2022, closing 4 positions and reducing 42 holdings. Its most notable exit was Axalta, an estimated $1.94M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in SEI Investments worth $1.7M.

  • Foyston, Gordon, & Payne's largest Q2 2022 buy was SEI Investments: 31,373 shares worth $1.7M.
  • Foyston, Gordon, & Payne added most to Alphabet (Google) Class A in Q2 2022, an estimated $2.5M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2022 reduction was Philip Morris, cutting an estimated $11.2M.
  • Foyston, Gordon, & Payne fully exited Axalta in Q2 2022, selling an estimated $1.94M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 43% of its $346M portfolio in Q2 2022.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 4 in Q2 2022.
  • Foyston, Gordon, & Payne's portfolio value fell 15% quarter-over-quarter to $346M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2022, filed 11 Aug 2022.